Impact of inhaled and intranasal corticosteroids on glucose metabolism and diabetes mellitus: A mini review.

Author: SeeKay Choong

Paper Details 
Original Abstract of the Article :
Inhaled corticosteroids (ICS) and intranasal corticosteroids (INS) are the mainstays of treatment for chronic respiratory diseases like asthma, chronic obstructive pulmonary disease, and allergic rhinosinusitis. In addition, these localized forms of steroid therapy are generally considered to have f...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473946/

データ提供:米国国立医学図書館(NLM)

Inhaled Corticosteroids: A Balancing Act for Respiratory Health

The field of respiratory medicine, like a desert landscape with diverse challenges, often requires a delicate balance between benefits and risks. Inhaled corticosteroids (ICS) and intranasal corticosteroids (INS) are commonly used to manage chronic respiratory conditions, but concerns persist regarding their potential impact on glucose metabolism and diabetes mellitus. This study, like a wise desert nomad navigating a complex terrain, explores the potential risks and benefits of using ICS and INS.

The study reviews the evidence linking high-dose ICS use with increased risk of incident diabetes and worsened diabetes control, while also acknowledging the need for further research to fully understand the association. It also discusses the potential risks of INS use in relation to hyperglycemia.

Navigating the Complexities of Corticosteroid Use

This study emphasizes the importance of careful consideration and a balanced approach to using ICS and INS. The researchers, much like skilled desert navigators, provide valuable insights into the potential risks and benefits of these medications, highlighting the need for individualized treatment plans.

Prioritizing Respiratory Health and Glucose Control

The study's findings underscore the importance of minimizing ICS and INS doses whenever possible and considering alternative management strategies. It emphasizes the need for personalized treatment plans that address both respiratory health and glucose control, particularly in individuals with diabetes or at risk of developing the condition.

Dr.Camel's Conclusion

The use of ICS and INS, like a desert oasis providing relief from harsh conditions, can offer significant benefits for respiratory health. However, it's crucial to approach their use with a balanced and informed perspective, considering the potential risks and benefits for each individual. By carefully navigating this complex terrain, we can optimize patient outcomes and minimize potential complications.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-09-05
Further Info :

Pubmed ID

37664474

DOI: Digital Object Identifier

PMC10473946

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.